For a Medicare beneficiary, is a colonoscopy covered after completing a Cologuard test?

Medicare Coverage for Colonoscopy After Positive Cologuard

Yes, Medicare covers colonoscopy after a positive Cologuard test, and as of January 2,2023, this follow-up colonoscopy is covered with no patient cost-sharing (0% coinsurance). This represents a significant policy change that removes financial barriers to completing the colorectal cancer screening process 1, 2.

Understanding the Coverage Policy

Historical Context

Prior to 2023, Medicare beneficiaries faced a problematic coverage gap. While the initial Cologuard test was covered as a screening test without cost-sharing, the follow-up colonoscopy after a positive result was classified as a diagnostic procedure, requiring patients to pay 20% coinsurance 3, 4. This created a financial barrier that discouraged completion of the screening process.

Current Coverage (2023 Forward)

The policy change eliminates this barrier entirely:

• Initial Cologuard screening: Covered with no cost-sharing
• Follow-up colonoscopy after positive Cologuard: Covered with no cost-sharing (0% coinsurance) 1
• Polyp removal during colonoscopy: Also covered without cost-sharing under the new policy

Clinical Rationale for Follow-Up Colonoscopy

All patients with positive stool-based tests (including Cologuard) must undergo colonoscopy to complete the screening process 5. This is not optional—it is a mandatory component of the two-step screening strategy:

1. Step 1: Cologuard detects potential abnormalities
2. Step 2: Colonoscopy confirms or rules out cancer, advanced adenomas, or other pathology

The screening process is incomplete without the follow-up colonoscopy, as the stool test alone cannot determine whether the positive result indicates cancer, precancerous polyps, or other conditions 5.

Expected Impact of the Policy Change

Research modeling suggests this policy change will have meaningful clinical benefits 1, 2:

• Increased screening participation: Estimated 5-15% increase in overall screening rates
• Improved follow-up rates: Estimated 5-15% increase in colonoscopy completion after positive tests
• Lives saved: Up to 26 additional life-years gained per 1,000 individuals
• Cost-effectiveness: The policy becomes cost-saving with any increase in screening or follow-up rates, as reduced colorectal cancer treatment costs offset increased screening costs 2

Common Pitfalls to Avoid

For Patients

• Don't delay the colonoscopy: Follow-up should occur promptly after a positive Cologuard result
• Don't assume you'll have out-of-pocket costs: The new policy eliminates coinsurance for the follow-up procedure
• Don't skip the colonoscopy: A positive Cologuard without colonoscopy follow-up leaves you at risk for undiagnosed cancer

For Providers

• Ensure patients understand coverage: Many beneficiaries may not be aware of the policy change and might avoid colonoscopy due to perceived cost barriers
• Document appropriately: Code the colonoscopy as follow-up to positive screening test to ensure proper coverage
• Track completion rates: Monitor whether patients complete the two-step screening process

Screening Intervals

According to current guidelines 5:

• Cologuard (multitarget stool DNA test): Every 3 years if negative
• Follow-up colonoscopy timing: Should be performed promptly after positive result
• If colonoscopy is negative: Return to routine screening intervals based on colonoscopy findings (typically 10 years if completely normal) 6, 7

The elimination of cost-sharing for follow-up colonoscopy represents evidence-based policy that aligns financial incentives with clinical best practices, potentially reducing colorectal cancer mortality in the Medicare population 1, 2, 3.